SCHEMBL95883

SCHEMBL95883

[CH2]c1ccc(C(=O)Nc2ccc(S(N)(=O)=O)cc2)cc1

nearest known ligand 0.84

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CA2 P00918 13/20 0.84
CA1 P00915 12/20 0.84
CA9 Q16790 8/20 0.74
CA12 O43570 4/20 0.74
KMT2A Q03164 6/20 0.68
MEN1 O00255 5/20 0.68
NPSR1 Q6W5P4 2/20 0.68
PSMD14 O00487 2/20 0.68
POLB P06746 2/20 0.68
MAPT P10636 2/20 0.68
CACNA1B Q00975 2/20 0.68
APBA1 Q02410 2/20 0.68
RECQL P46063 1/20 0.68
CTDSP1 Q9GZU7 1/20 0.68
SAE1 Q9UBE0 1/20 0.68
UBA2 Q9UBT2 1/20 0.68
FGB P02675 1/20 0.59
CYP2C9 P11712 1/20 0.59
CYP2C19 P33261 1/20 0.59
PLEC Q15149 1/20 0.59

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6225517 0.84 CA1 (0.84) CA2CA1CA9CA12KMT2A
SCHEMBL13980021 0.84 CA1 (0.84) CA2CA1CA9CA12KMT2A
SCHEMBL8421687 0.84 CA2 (0.84) CA2CA1CA9CA12KMT2A
SCHEMBL27468719 0.84 CA2 (0.84) CA2CA1CA9CA12KMT2A
SCHEMBL8422583 0.83 CA2 (1.00) CA2CA1CA9CA12KMT2A
SCHEMBL8804052 0.83 CA1 (0.81) CA2CA1CA9CA12KMT2A
SCHEMBL27482936 0.83 CA2 (0.81) CA2CA1CA9CA12KMT2A
SCHEMBL9449429 0.80 CA2 (0.77) CA2CA1CA9CA12KMT2A
SCHEMBL20284431 0.80 CA2 (0.77) CA2CA1CA9CA12KMT2A
SCHEMBL11698866 0.80 CA2 (0.77) CA2CA1CA9CA12KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 13 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8362252-B2 Carbostyril compound OTSUKA PHARMACEUTICAL CO., LTD. (JP) 2013-01-29 US disclosed
EP-1797082-B1 CARBOSTYRIL COMPOUND OTSUKA PHARMA CO LTD (JP) 2012-08-29 EP disclosed
EP-2426128-A1 Carbostyril compound Otsuka Pharmaceutical Co., Limited (JP) 2012-03-07 EP disclosed
US-20100261705-A1 CARBOSTYRIL COMPOUND OTSUKA PHARMACEUTICAL CO., LTD. 2010-10-14 US disclosed
US-7777038-B2 Carbostyril compound OTSUKA PHARMACEUTICAL CO., LTD. (JP) 2010-08-17 US disclosed
US-20090326008-A1 NF-kappa B Inhibitor OTSUKA PHARMACEUTICAL CO., LTD. (JP) 2009-12-31 US disclosed
EP-2043644-A1 NF- B INHIBITOR Otsuka Pharmaceutical Co., Ltd. (JP) 2009-04-08 EP disclosed
WO-2007119600-A9 CARBAZOLE COMPOUND OTSUKA PHARMA CO LTD (JP) 2008-05-02 WO disclosed
WO-2008010601-A1 NF- ϰB INHIBITOR OTSUKA PHARMACEUTICAL CO., LTD. (JP) 2008-01-24 WO disclosed
WO-2007119600-A1 CARBAZOLE COMPOUND OTSUKA PHARMACEUTICAL CO., LTD. (JP) 2007-10-25 WO disclosed
US-20070179173-A1 Carbostyril compound OTSUKA PHARMACEUTICAL CO., LTD. (JP) 2007-08-02 US disclosed
EP-1797082-A1 CARBOSTYRIL COMPOUND Otsuka Pharmaceutical Company, Limited (JP) 2007-06-20 EP disclosed
WO-2006035954-A1 CARBOSTYRIL COMPOUND OTSUKA PHARMACEUTICAL CO., LTD. (JP) 2006-04-06 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090326008-A1 NF-kappa B Inhibitor NFKBIA, NFKB2, IKBKB CA2 823/4885CA1 3276/4885CA9 2466/4885
US-20070179173-A1 Carbostyril compound GTF2F1, F3, GTF2F2 CA2 254/4885CA1 2592/4885CA9 895/4885
US-20100261705-A1 CARBOSTYRIL COMPOUND GTF2F1, F3, GTF2F2 CA2 254/4885CA1 2592/4885CA9 895/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.